Topics

Zoetis and Nexvet Biopharma plc Company Profile

10:30 EST 21st January 2020 | BioPortfolio

Zoetis (NYSE: ZTS) is the leading animal health company, dedicated to supporting its customers and their businesses. Building on more than 60 years of experience in animal health, Zoetis discovers, develops, manufactures and markets veterinary vaccines and medicines, complemented by diagnostic products, genetic tests, biodevices and a range of services. Zoetis serves veterinarians, livestock producers and people who raise and care for farm and companion animals with sales of its products in more than 100 countries. In 2016, the company generated annual revenue of US$4.9 billion with approximately 9,000 employees. For more information, visit www.Zoetis.com.


News Articles [885 Associated News Articles listed on BioPortfolio]

Zoetis to Participate in the 38th Annual J.P. Morgan Healthcare Conference

Zoetis Inc. (NYSE:ZTS) will participate in the 38th Annual J.P. Morgan Healthcare Conference on Tuesday, Jan. 14, 2020, in San Francisco, Calif. Kristin Peck, who will become Chief Executive Officer ...

Zoetis - Galloping To Glory

Shares of Zoetis Inc. (ZTS) touched an all-time high of $124.34 in intraday trading yesterday (Aug.7), and that represents a gain of nearly 47 percent year-to-date.

Zoetis to Participate in the William Blair 39th Annual Growth Stock Conference

Zoetis Inc. (NYSE:ZTS) will participate in the William Blair 39th Annual Growth Stock Conference on Thursday, June 6, 2019, in Chicago, Ill. Juan Ramón Alaix, Chief Execut...

Zoetis to Host Webcast and Conference Call on Third Quarter 2019 Financial Results

Zoetis Inc. (NYSE:ZTS) will host a webcast and conference call at 8:30 a.m. (ET) on Thursday, Nov. 7, 2019. Chief Executive Officer Juan Ramón Alaix and Executive Vice President and Chief Financial ...

Did Zoetis Catch Your Eye?

Zoetis is an animal health company - catering to the health of cattle, pigs, poultry, sheep, fish, dogs, cats and horses. The Company has roughly 300 product lines, which are sold in more than 100 cou...

Zoetis to Host Webcast and Conference Call on Second Quarter 2019 Financial Results

Zoetis Inc. (NYSE:ZTS) will host a webcast and conference call at 8:30 a.m. (ET) on Tuesday, Aug. 6, 2019. Chief Executive Officer Juan Ramón Alaix and Executive Vice President and Chief Financial O...

Zoetis to Participate in the Credit Suisse 28th Annual Healthcare Conference

Zoetis Inc. (NYSE:ZTS) will participate in the Credit Suisse 28th Annual Healthcare Conference on Tuesday, Nov. 12, 2019, in Scottsdale, Ariz. Kristin Peck, CEO-elect, Executive Vice President and Gr...

Zoetis to Participate in the Morgan Stanley 17th Annual Global Healthcare Conference

Zoetis Inc. (NYSE:ZTS) will participate in the Morgan Stanley 17th Annual Global Healthcare Conference on Tuesday, Sept. 10, 2019, in New York, N.Y. Glenn David, Executive Vice President and Chief Fi...

Drugs and Medications [9 Associated Drugs and Medications listed on BioPortfolio]

Alferon [hemispherx biopharma, inc]

NA

Yupelri [the ritedose corporation]

Yupelri (Revefenacin) Inhalation Solution 175 mcg/3 mL

Keveyis [strongbridge us inc.]

These highlights do not include all the information needed to use KEVEYIS safely and effectively. See full prescribing information for KEVEYIS. KEVEYIS (dichlorphenamide) tablets, for oral use Initial...

Macrilen [strongbridge u.s. inc]

These highlights do not include all the information needed to use MACRILEN safely and effectively. See full prescribing information for MACRILEN.MACRILEN (macimorelin) for oral solution Initial U.S. A...

Recombinate [baxter healthcare corporation]

RECOMBINATE [Antihemophilic Factor (Recombinant)]

PubMed Articles [7 Associated PubMed Articles listed on BioPortfolio]

Native and Denaturing MS Protein Deconvolution for Biopharma: Monoclonal Antibodies and Antibody-Drug-Conjugates to Polydisperse Membrane Proteins and Beyond.

Electrospray ionization mass spectrometry (ESI-MS) is a ubiquitously used analytical method applied across multiple departments in biopharma, ranging from early Research Discovery to Process Developme...

CDx, NGS and regulation: five perspectives from the Pistoia Alliance.

Companion diagnostics (CDx) are essential to the practice of precision medicine. Next-generation sequencing is an increasingly important tool in the development of CDx. However, for CDx to be deployed...

How the Globe Celebrated World Vitiligo Day 2019.

A week-long World Vitiligo Day campaign culminates efforts of numerous activists around the world to bring this once forgotten skin disease to the attention of general public, healthcare system and bi...

Data science tools and applications on the way to Pharma 4.0.

Multiple obstacles are driving the digital transformation of the biopharmaceutical industry. Novel digital techniques, often marketed as 'Pharma 4.0', are thought to solve some long-existing obstacles...

In vitro and in vivo effects of toceranib phosphate on canine osteosarcoma cell lines and xenograft orthotopic models.

Canine osteosarcoma (OSA) is the most common primary malignant bone tumour in dogs, and it has a high metastatic rate and poor prognosis. Toceranib phosphate (TOC) (Palladia, Zoetis, U.S.A.) is a vete...

Clinical Trials [4 Associated Clinical Trials listed on BioPortfolio]

A Study of Orally Administered ZM-H1505R to Evaluate Safety, Tolerability and Pharmacokinetics After Single and Multiple Ascending Doses in Healthy Participants

ZM-H1505R is an investigational drug developed by Shanghai Zhimeng Biopharma Inc. for the treatment of Chronic Hepatitis B. The purpose of this study is to see how safe the study drug is ...

Single Ascending Dose Phase 1 Trial in Patients With Type 2 Diabetes

ARRY-403 is an investigational new drug being developed by Array BioPharma Inc. for treating Type 2 diabetes. The purpose of this study is to test the safety (potential side effects) and ...

A Phase 1b Study Evaluating RESTEN-MP in Subjects With Focal de Novo Stenosis

The process of re-narrowing of a coronary artery following a revascularization procedure such as angioplasty, begins at the time of the procedure. Restenosis has long been considered a ma...

Safety and Efficacy of RESTEN-MP When Used in Conjunction With a Bare Metal Stent in Coronary Arteries

The process of re-narrowing of a coronary artery following a revascularization procedure such as angioplasty, begins at the time of the procedure. Restenosis has long been considered a ma...

Companies [170 Associated Companies listed on BioPortfolio]

Zoetis and Nexvet Biopharma plc

Zoetis (NYSE: ZTS) is the leading animal health company, dedicated to supporting its customers and their businesses. Building on more than 60 years of experience in animal health,...

Nexvet Biopharma

Zoetis, Inc.

Zoetis (zô-EH-tis) is the leading animal health company, dedicated to supporting its customers and their businesses. Building on more than 60 years of experience in animal heal...

Zoetis

Zoetis (zō-EH-tis) is the leading animal health company, dedicated to supporting its customers and their businesses. Building on a 60-year history as the animal health business...

Zoetis Inc.

Zoetis (zō-EH-tis) is the leading animal health company, dedicated to supporting its customers and their businesses. Building on a 60-year history as the animal health business...

More Information about "Zoetis and Nexvet Biopharma plc" on BioPortfolio

We have published hundreds of Zoetis and Nexvet Biopharma plc news stories on BioPortfolio along with dozens of Zoetis and Nexvet Biopharma plc Clinical Trials and PubMed Articles about Zoetis and Nexvet Biopharma plc for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Zoetis and Nexvet Biopharma plc Companies in our database. You can also find out about relevant Zoetis and Nexvet Biopharma plc Drugs and Medications on this site too.

Quick Search

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...


Corporate Database Quicklinks



Searches Linking to this Company Record